Supportive and Palliative Care in Head and Neck CancerInfo Course InformationApproximately 1/3 of patients referred through for oncological management of their head and neck cancer within Merseyside will undergo a palliative treatment strategy. In addition, local relapse rates for those initially treated with radical intent (with HPV negative disease) approach 50%. This meeting is designed to encourage members within H&N MDT to attend and engage in disccussing complex decisions regarding patient care. Supportive and Palliative Care in Head and Neck Cancer_agenda.docx
Course CodeLHNC19 Course LeaderDr Rachel Brooker
|